AI is collapsing drug discovery timelines.
Pharma content still drags through weeks of MLR.
Until now.
25K Free Credits (Launch Offer)
Loved by marketing teams at
NovaCura: HCP Education Reel
CardiometabolicMagic Video · 16:9 · en-US




25K Free Credits (Launch Offer)
Approved content
arrives too late.
5 Digital Co-workers. One Platform.
Brief them like your best hires, each pre-trained on the last 12 years of Approved Assets and Award Winning campaigns.

Project Manager
Orchestrates
Content Strategist
Plans
Medical Writer
Writes
Creative Producer
Creates
MLR Reviewer
Clears itMarketing Objectives
Core commercial goals mapped from one brief
Audience Segments
Priority audiences planned before production starts
Content Formats
Approved formats produced through five Magic Engines
Time Savings
Less time from brief to review-ready content
Cost Savings
Lower production cost across repeatable assets
MLR Cycle Time
Shorter review cycles with evidence built in
Industry’s First Brand Dossier To Power
30+ Formats. Every Objective. Every Audience.
Five Magic Engines share one Brand Dossier, grounded in medically referenced citations, so every format stays on-brand, on-label, and review-ready.
The Reasoning Model Built for Life Sciences
Glorious, compliant and as desired on the first attempt
Five dedicated co-workers shape the brief before production starts.
Each shot gets routed to the model best suited for its motion, tone, and format.
Multi-model routing
On-label by construction
Off-label language, missing fair balance, and unlinked claims are structurally prevented, not caught in review.
Proprietary reasoning, purpose-built for life sciences.
How the brief gets processed
Brief decoded
Context harnessed
Prompts layered
Claims linked
Model routed
Output verified
Every model knows medicine.
None of them know your brand.
General AI guesses at your brand. SwishX starts from your own verified Brand Dossier, so every asset already knows what’s true.
Technology partners
Built with the best in Frontier AI
OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



OpenAI



Feeds your Veeva and Cortex workflow. Does not replace it.
SwishX pulls your approved claims and references in, and pushes submission-ready packages out, every claim annotated to its source. It sits upstream of your MLR system, feeding it content that is already clean.
Generates clean, referenced, submission-ready content
PromoMatsReviews and approves, exactly as it does today
Brief in. Review-ready out.
3 steps from a blank page to an asset your MLR committee can clear in one pass.
Start from your Brand Dossier
Point SwishX at your own materials, or let us build your Brand Dossier: a single source of truth across the drug, the disease, and the therapeutic area.
- Approved label, PI, and clinical references
- Core claims, mapped to their evidence
- Disease-state and therapeutic-area context
- One source every co-worker generates from

Brand Dossier
Single source of truth
Set the brief
Choose the format, the objective, and the goal, then dial in the details that make it yours.
- Format, objective, and funnel stage
- Audience, tone of voice, and language
- Generate the script, or refine your own
- Apply your brand colors and brand kit

Get a review-ready asset
In minutes: every claim referenced, fair balance in place, ready to enter MLR clean.
- Citations shown by default
- Fair balance and ISI already placed
- Edit any component just by chatting
- Full flexibility on copy, visuals, structure

Tighten the headline
Security and compliance,
engineered in, not bolted on.
Every layer of SwishX is built to the standards pharma and medtech commercial teams already answer to.
21 CFR 202.1
MLR-ready by design

GDPR
Compliant

HIPAA
Compliant

SOC 2
Type II compliant
TLS 1.2+
Every connection encrypted

AES-256
Encrypted at rest
Full detail on our practices is available on the Security Page.
See it run on your own brand.
Book a 30-minute demo and watch a brief become a review-ready asset before the call ends. Or start free and make one yourself.




